Oncology & Cancer

New study targets major risk factor for gastric cancer

What if we could eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable populations? A new study from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of ...


Discovery sets stage for vaccine against gastric cancer, ulcers

H. pylori is one of the most common disease-causing bacteria. More than half of the world's population have the bacteria in their body; and while in Canada overall prevalence of H. pylori is between 20% and 30%, some groups—including ...

Oncology & Cancer

Treating stomach cancer

More than 26,000 people in the U.S. will be diagnosed with stomach cancer this year, and nearly 11,000 people will die of the disease, according to the American Cancer Society. Stomach cancer accounts for about 1.5% of all ...

Oncology & Cancer

Genomic profiling offers early clues to stomach cancer development

In a breakthrough study published in Cancer Cell, researchers have decoded critical genetic factors in intestinal metaplasia patients, shedding light on early signs and prevention strategies for stomach cancer—often a "ticking ...


Aspirin may benefit cancer treatments

Aspirin is an inexpensive and readily available medication that could benefit cancer treatments, preventing metastatic cancer spread and reducing vascular complications, finds a new meta-analysis study.

page 1 from 23

Stomach cancer

Stomach or gastric cancer can develop in any part of the stomach and may spread throughout the stomach and to other organs; particularly the esophagus, lungs and the liver. Stomach cancer causes about 800,000 deaths worldwide per year.

This text uses material from Wikipedia, licensed under CC BY-SA